Immunome (IMNM) Change in Cash (2019 - 2026)
Immunome's (IMNM) quarterly Change in Cash came in at -$70.8 million in Q1 2026, down 161.95% YoY from $114.3 million in Q1 2025, and down 118.59% on a QoQ basis from $380.8 million in Q4 2025.
Immunome (IMNM) Change in Cash (2019 - 2026) Analysis & Trends
Immunome (IMNM) has 8 years of Change in Cash data on file, last reported at -$70.8 million in Q1 2026.
- Quarterly Change in Cash fell 161.95% year-over-year to -$70.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $325.2 million (up 2785.3% YoY) and the FY2025 annual result came in at $510.2 million, up 1042.19% from the prior year.
- Change in Cash declined to -$70.8 million in Q1 2026, from $380.8 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $380.8 million in Q4 2025 to a low of -$113.6 million in Q2 2025.
- A 5-year average of $31.4 million and a median of -$6.4 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash slumped 1637.53% — and 2025, when it soared 3217.32%.
- Tracing IMNM's Change in Cash over 5 years: stood at -$6.8 million in 2022, then soared by 218.99% to $8.0 million in 2023, then tumbled by 251.99% to -$12.2 million in 2024, then soared by 3217.32% to $380.8 million in 2025, then sank by 118.59% to -$70.8 million in 2026.
- The last three Change in Cash figures came in at -$70.8 million (Q1 2026), $380.8 million (Q4 2025), and $128.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Immunome | 3.09 Bn | 2.57 Bn | - | -364.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -364.99 Mn |
| Mar 31, 2026 | -70.79 Mn |
| Dec 31, 2025 | 380.84 Mn |
| Sep 30, 2025 | 128.76 Mn |
| Jun 30, 2025 | -113.63 Mn |
| Mar 31, 2025 | 114.26 Mn |
| Dec 31, 2024 | -12.22 Mn |
| Sep 30, 2024 | -9.76 Mn |
| Jun 30, 2024 | -104.39 Mn |
| Mar 31, 2024 | 171.04 Mn |
| Dec 31, 2023 | 8.04 Mn |
| Sep 30, 2023 | 52.23 Mn |
| Jun 30, 2023 | -6.01 Mn |
| Mar 31, 2023 | 24.10 Mn |
| Dec 31, 2022 | -6.76 Mn |
| Sep 30, 2022 | -7.57 Mn |
| Jun 30, 2022 | -8.23 Mn |
| Mar 31, 2022 | -6.35 Mn |
| Dec 31, 2021 | -7.01 Mn |
| Sep 30, 2021 | -3.59 Mn |